Edwards Lifesciences Corporation Comments On German Appellate Court Ruling

Published: Nov 15, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, CA--(Marketwired - Nov 14, 2013) - Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today said that an appeals court in Germany has suspended the enforcement of an injunction against sales of Medtronic's transcatheter heart valves in Germany, pending the posting of a EUR 5 million bond by Medtronic. This action comes after the European Patent Office (EPO) issued a non-binding preliminary opinion in October indicating concerns about the validity of the Edwards Spenser patent.

Help employers find you! Check out all the jobs and post your resume.

Back to news